Skip to main content
OpenTrials
Completed

NCT Number: NCT06018753

Umbrella Study for Analysis of Data Related to Patients With Cancer

This study is a multisite, minimal risk, non-interventional study using patient electronic health record data collected as part of standard of care to answer cohort-based research questions and create robust real-world data sets.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Neoplasms

Sex eligibility

All sexes

Study type

Observational

Primary location

Memorial Health Services, Fountain Valley, California, United States

Loading trial locations.

About this study

One key purpose of the Study is to collect data that may be used for a wide range of scientific questions and real-world insights.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects must be diagnosed with cancer
  • Medical records available to meet cohort requirements

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. Provide RWD/E Datasets to Research Collaborators to Support Development

    Time frame: 5 years

    Use data analysis to enable deeper understanding of patient population characteristics and outcomes to more accurately assess clinical trial feasibility and optimize trial design.

  2. Provide RWD/E Datasets to Research Collaborators to Support Regulatory

    Time frame: 5 years

    Use data analysis to generate supplemental data for new accelerated approval pathway filings and provide real world control arms where necessary.

  3. Provide RWD/E Datasets to Research Collaborators to Support Commercialization

    Time frame: 5 years

    Use data analysis to enable more precise characterization of biomarker testing rates, factors influencing access to testing, and uptake of recently approved therapies to inform commercial strategy for pharmaceutical companies and generate evidence for payors.

  4. Provide RWD/E Datasets to Research Collaborators to Support Phase IV Surveillance

    Time frame: 5 years

    Use data analysis to support post approval understanding of longer term side effects that may not be sufficiently detected via randomized clinical trials.

  5. Provide RWD/E Datasets to Research Collaborators to Support Real-World Insights

    Time frame: 5 years

    Use data analysis to further understanding of variations in patient care across the US to help ensure patients have access to optimal testing and treatment.

Sponsors and collaborators

Lead sponsor

Tempus AI

Industry

Registry information

Acronym: Polaris

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Aug 31, 2023
Registry last updated
Jun 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.